Category: CAS Medical Systems Inc.
Here's a look at some of the top legal news stories for medical device companies this week: Guidant can't slip breach-of-contract charges in Johnson & Johnson suit; Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico; Appeals court upholds Retractable Technologies win over Becton Dickinson; Board suspends ex-PricewaterhouseCoopers accountant over ArthroCare scandal; Covidien's Nellcor and CAS Medical settle dispute for $275k
, Becton Dickinson & Co.
, Boston Scientific
, CAS Medical Systems Inc.
, Dept. of Justice (DOJ)
, Guidant Corp.
, Johnson & Johnson
, Public Company Accounting Oversight Board
, Retractable Technologies Inc.
, Securities & Exchange Commission (SEC)
, Abbott Laboratories
Nellcor agrees to drop its litigation in return for a $275,000 payment and a promise from Nellcor to drop its claims for legal fees.
A federal judge tosses 1 count of a patent infringement lawsuit filed by Covidien's Nellcor subsidiary against CAS Medical over patient monitoring technology.
A survey of CEOs and venture capital players reveals the gap between what CEOs want from their backers and what VCs think CEOs want.
A survey of 158 CEOs and 216 venture capital firms revealed a large gap between the chief executives' wish list for potential backers and what VCs think the CEOs want.
Startup CEOs in the IT and life science industries want VCs who are "entrepreneur friendly" and "collaborative" without being too hands-on in their approach, according to a survey sponsored by the National Venture Capital Assn.
Covidien's Nellcor patient monitoring subsidiary wants a judge to stop CAS Medical Systems from protesting the validity of a patent with the U.S. Patent & Trademark Office.
Shares of Accuray fall nearly 10% after the radiosurgery device maker lowers its sales forecast for the full year; plus, Q1 sales, earnings up for Henry Schein; LeMaitre Vascular's Q1 profits soar; Mindray's Q1 profits slide despite double-digit sales boost; Stereotaxis boosts Q1 sales, slashes losses; Steris profits spike in 2011; Symmetry Medical's Q1 bottom line plunges; Syneron boosts Q1 sales, losses widen; and more.
Accuray (NSDQ:ARAY) shares are down nearly 10% today as investors react to wider 3rd-quarter losses and a lower sales forecast for the rest of fiscal 2012.
The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.
CAS Medical Systems Inc.
, Delcath Systems Inc.
, Henry Schein Inc.
, Mindray Medical International Ltd.
, Misonix Inc.
, Response Biomedical Corp.
, Stereotaxis Inc.
, Steris Corp.
, SurModics Inc.
, Symmetry Medical Inc.
, Syneron Medical Ltd.
, Tornier Inc.
, Accuray Inc.
, Zynex Inc.
Elekta's Q3 sales spike, earnings soar; Essilor's 2011 sales, earnings rise; DGT's sales rise, profits soar on divestiture; Q4, 2011 sales slump, losses widen for Stereotaxis; Sales, earning slide for Iridex in Q4; Losses soar for Imris in 2011; CasMed's sales slide, losses widen for Q4, 2011; and Oridion's 2011 sales rise, profits slide.
Elekta's Q3 sales spike, earnings soar